Cargando…

The role of the MYD88-dependent pathway in MPTP-induced brain dopaminergic degeneration

BACKGROUND: Mounting evidence supports a significant role of inflammation in Parkinson's disease (PD) pathophysiology, with several inflammatory pathways being suggested as playing a role in the dopaminergic degeneration seen in humans and animal models of the disease. These include tumor necro...

Descripción completa

Detalles Bibliográficos
Autores principales: Drouin-Ouellet, Janelle, Gibrat, Claire, Bousquet, Mélanie, Calon, Frédéric, Kriz, Jasna, Cicchetti, Francesca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3203853/
https://www.ncbi.nlm.nih.gov/pubmed/21989292
http://dx.doi.org/10.1186/1742-2094-8-137
_version_ 1782215139893706752
author Drouin-Ouellet, Janelle
Gibrat, Claire
Bousquet, Mélanie
Calon, Frédéric
Kriz, Jasna
Cicchetti, Francesca
author_facet Drouin-Ouellet, Janelle
Gibrat, Claire
Bousquet, Mélanie
Calon, Frédéric
Kriz, Jasna
Cicchetti, Francesca
author_sort Drouin-Ouellet, Janelle
collection PubMed
description BACKGROUND: Mounting evidence supports a significant role of inflammation in Parkinson's disease (PD) pathophysiology, with several inflammatory pathways being suggested as playing a role in the dopaminergic degeneration seen in humans and animal models of the disease. These include tumor necrosis factor, prostaglandins and oxidative-related stress components. However, the role of innate immunity has not been established in PD. METHODS: Based on the fact that the myeloid differentiation primary response gene (88) (MyD88) is the most common adaptor protein implicated in toll-like receptor (TLR) signaling, critical in the innate immune response, we undertook a study to investigate the potential contribution of this specific pathway to MPTP-induced brain dopaminergic degeneration using MyD88 knock out mice (MyD88-/-), following our observations that the MyD88-dependent pathway was critical for MPTP dopaminergic toxicity in the enteric nervous system. Post-mortem analyses assessing nigrostriatal dopaminergic degeneration and inflammation were performed using HPLC, western blots, autoradiography and immunofluorescence. RESULTS: Our results demonstrate that MyD88-/- mice are as vulnerable to MPTP-induced dopamine and DOPAC striatal depletion as wild type mice. Furthermore, MyD88-/- mice show similar striatal dopamine transporter and tyrosine hydroxylase loss, as well as dopaminergic cell loss in the substantia nigra pars compacta in response to MPTP. To evaluate the extent of the inflammatory response created by the MPTP regimen utilized, we further performed bioluminescence imaging using TLR2-luc/gfp transgenic mice and microglial density analysis, which revealed a modest brain microglial response following MPTP. This was accompanied by a significant astrocytic reaction in the striatum, which was of similar magnitude both in wild type and MyD88-/- mice. CONCLUSIONS: Our results suggest that subacute MPTP-induced dopaminergic degeneration observed in the central nervous system is MyD88-independent, in contrast to our recent observations that this pathway, in the same cohort of animals, is critical in the loss of dopaminergic neurons in the enteric nervous system.
format Online
Article
Text
id pubmed-3203853
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32038532011-10-29 The role of the MYD88-dependent pathway in MPTP-induced brain dopaminergic degeneration Drouin-Ouellet, Janelle Gibrat, Claire Bousquet, Mélanie Calon, Frédéric Kriz, Jasna Cicchetti, Francesca J Neuroinflammation Research BACKGROUND: Mounting evidence supports a significant role of inflammation in Parkinson's disease (PD) pathophysiology, with several inflammatory pathways being suggested as playing a role in the dopaminergic degeneration seen in humans and animal models of the disease. These include tumor necrosis factor, prostaglandins and oxidative-related stress components. However, the role of innate immunity has not been established in PD. METHODS: Based on the fact that the myeloid differentiation primary response gene (88) (MyD88) is the most common adaptor protein implicated in toll-like receptor (TLR) signaling, critical in the innate immune response, we undertook a study to investigate the potential contribution of this specific pathway to MPTP-induced brain dopaminergic degeneration using MyD88 knock out mice (MyD88-/-), following our observations that the MyD88-dependent pathway was critical for MPTP dopaminergic toxicity in the enteric nervous system. Post-mortem analyses assessing nigrostriatal dopaminergic degeneration and inflammation were performed using HPLC, western blots, autoradiography and immunofluorescence. RESULTS: Our results demonstrate that MyD88-/- mice are as vulnerable to MPTP-induced dopamine and DOPAC striatal depletion as wild type mice. Furthermore, MyD88-/- mice show similar striatal dopamine transporter and tyrosine hydroxylase loss, as well as dopaminergic cell loss in the substantia nigra pars compacta in response to MPTP. To evaluate the extent of the inflammatory response created by the MPTP regimen utilized, we further performed bioluminescence imaging using TLR2-luc/gfp transgenic mice and microglial density analysis, which revealed a modest brain microglial response following MPTP. This was accompanied by a significant astrocytic reaction in the striatum, which was of similar magnitude both in wild type and MyD88-/- mice. CONCLUSIONS: Our results suggest that subacute MPTP-induced dopaminergic degeneration observed in the central nervous system is MyD88-independent, in contrast to our recent observations that this pathway, in the same cohort of animals, is critical in the loss of dopaminergic neurons in the enteric nervous system. BioMed Central 2011-10-11 /pmc/articles/PMC3203853/ /pubmed/21989292 http://dx.doi.org/10.1186/1742-2094-8-137 Text en Copyright ©2011 Drouin-Ouellet et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Drouin-Ouellet, Janelle
Gibrat, Claire
Bousquet, Mélanie
Calon, Frédéric
Kriz, Jasna
Cicchetti, Francesca
The role of the MYD88-dependent pathway in MPTP-induced brain dopaminergic degeneration
title The role of the MYD88-dependent pathway in MPTP-induced brain dopaminergic degeneration
title_full The role of the MYD88-dependent pathway in MPTP-induced brain dopaminergic degeneration
title_fullStr The role of the MYD88-dependent pathway in MPTP-induced brain dopaminergic degeneration
title_full_unstemmed The role of the MYD88-dependent pathway in MPTP-induced brain dopaminergic degeneration
title_short The role of the MYD88-dependent pathway in MPTP-induced brain dopaminergic degeneration
title_sort role of the myd88-dependent pathway in mptp-induced brain dopaminergic degeneration
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3203853/
https://www.ncbi.nlm.nih.gov/pubmed/21989292
http://dx.doi.org/10.1186/1742-2094-8-137
work_keys_str_mv AT drouinouelletjanelle theroleofthemyd88dependentpathwayinmptpinducedbraindopaminergicdegeneration
AT gibratclaire theroleofthemyd88dependentpathwayinmptpinducedbraindopaminergicdegeneration
AT bousquetmelanie theroleofthemyd88dependentpathwayinmptpinducedbraindopaminergicdegeneration
AT calonfrederic theroleofthemyd88dependentpathwayinmptpinducedbraindopaminergicdegeneration
AT krizjasna theroleofthemyd88dependentpathwayinmptpinducedbraindopaminergicdegeneration
AT cicchettifrancesca theroleofthemyd88dependentpathwayinmptpinducedbraindopaminergicdegeneration
AT drouinouelletjanelle roleofthemyd88dependentpathwayinmptpinducedbraindopaminergicdegeneration
AT gibratclaire roleofthemyd88dependentpathwayinmptpinducedbraindopaminergicdegeneration
AT bousquetmelanie roleofthemyd88dependentpathwayinmptpinducedbraindopaminergicdegeneration
AT calonfrederic roleofthemyd88dependentpathwayinmptpinducedbraindopaminergicdegeneration
AT krizjasna roleofthemyd88dependentpathwayinmptpinducedbraindopaminergicdegeneration
AT cicchettifrancesca roleofthemyd88dependentpathwayinmptpinducedbraindopaminergicdegeneration